These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21540026)

  • 21. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
    Yasuda M
    J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.
    Risinger JI; Maxwell GL; Chandramouli GV; Jazaeri A; Aprelikova O; Patterson T; Berchuck A; Barrett JC
    Cancer Res; 2003 Jan; 63(1):6-11. PubMed ID: 12517768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer.
    Mokhtar NM; Ramzi NH; Yin-Ling W; Rose IM; Hatta Mohd Dali AZ; Jamal R
    Cancer Invest; 2012 Feb; 30(2):156-64. PubMed ID: 22122087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of clusterin according to histological type of endometrial carcinoma.
    Ahn HJ; Bae J; Lee S; Ko JE; Yoon S; Kim SJ; Sakuragi N
    Gynecol Oncol; 2008 Aug; 110(2):222-9. PubMed ID: 18514801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
    Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
    Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma].
    Wang LX; Zhou CW; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):849-53. PubMed ID: 20137351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
    Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC
    Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.
    Shih IeM; Wang TL
    J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 33. Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma.
    Sakuragi N; Hirai A; Tada M; Yamada H; Yamamoto R; Fujimoto S; Moriuchi T
    Gynecol Oncol; 2001 Dec; 83(3):485-90. PubMed ID: 11733960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of the miRNA-200 family in endometrial endometrioid carcinoma.
    Lee JW; Park YA; Choi JJ; Lee YY; Kim CJ; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
    Gynecol Oncol; 2011 Jan; 120(1):56-62. PubMed ID: 21035172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
    Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
    Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of mutation profiles to refine the classification of endometrial carcinomas.
    McConechy MK; Ding J; Cheang MC; Wiegand K; Senz J; Tone A; Yang W; Prentice L; Tse K; Zeng T; McDonald H; Schmidt AP; Mutch DG; McAlpine JN; Hirst M; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
    J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
    Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
    Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
    Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.